vs
GE医疗（DHC）与Dynatrace, Inc.（DT）财务数据对比。点击上方公司名可切换其他公司
Dynatrace, Inc.的季度营收约是GE医疗的1.4倍（$515.5M vs $379.6M），Dynatrace, Inc.净利率更高（7.8% vs -5.6%，领先13.4%），Dynatrace, Inc.同比增速更快（18.2% vs -0.0%），Dynatrace, Inc.自由现金流更多（$27.2M vs $-166.4M），过去两年Dynatrace, Inc.的营收复合增速更高（16.3% vs 1.2%）
GE医疗是一家总部位于美国伊利诺伊州芝加哥市的医疗科技企业，业务涵盖四大板块：医疗影像设备，包括分子成像、CT、核磁共振、妇科健康筛查及X光系统；超声设备；患者护理解决方案，聚焦远程患者监测、麻醉呼吸护理、心脏诊断及婴幼儿护理；此外还涉及医药相关领域，是全球医疗行业的知名企业。
Dynatrace是总部位于美国的跨国科技企业，主打AI驱动的可观测性平台，旗下软件可用于应用性能监控分析、软件开发流程优化、网络安全防护、IT基础设施运维及用户体验提升等场景，为各行业客户的数字化运营提供有力技术支撑。
DHC vs DT — 直观对比
营收规模更大
DT
是对方的1.4倍
$379.6M
营收增速更快
DT
高出18.2%
-0.0%
净利率更高
DT
高出13.4%
-5.6%
自由现金流更多
DT
多$193.7M
$-166.4M
两年增速更快
DT
近两年复合增速
1.2%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $379.6M | $515.5M |
| 净利润 | $-21.2M | $40.1M |
| 毛利率 | — | 81.4% |
| 营业利润率 | -12.6% | 14.1% |
| 净利率 | -5.6% | 7.8% |
| 营收同比 | -0.0% | 18.2% |
| 净利润同比 | 75.7% | -88.9% |
| 每股收益（稀释后） | $-0.09 | $0.13 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DHCDT
| Q4 25 | $379.6M | $515.5M | ||
| Q3 25 | $388.7M | $493.8M | ||
| Q2 25 | $382.7M | $477.3M | ||
| Q1 25 | $386.9M | $445.2M | ||
| Q4 24 | $379.6M | $436.2M | ||
| Q3 24 | $373.6M | $418.1M | ||
| Q2 24 | $371.4M | $399.2M | ||
| Q1 24 | $370.8M | $380.8M |
净利润DHCDT
| Q4 25 | $-21.2M | $40.1M | ||
| Q3 25 | $-164.0M | $57.2M | ||
| Q2 25 | $-91.6M | $48.0M | ||
| Q1 25 | $-9.0M | $39.3M | ||
| Q4 24 | $-87.4M | $361.8M | ||
| Q3 24 | $-98.7M | $44.0M | ||
| Q2 24 | $-97.9M | $38.6M | ||
| Q1 24 | $-86.3M | $37.9M |
毛利率DHCDT
| Q4 25 | — | 81.4% | ||
| Q3 25 | — | 81.8% | ||
| Q2 25 | — | 82.1% | ||
| Q1 25 | — | 80.9% | ||
| Q4 24 | — | 81.1% | ||
| Q3 24 | — | 81.4% | ||
| Q2 24 | — | 81.3% | ||
| Q1 24 | — | 81.1% |
营业利润率DHCDT
| Q4 25 | -12.6% | 14.1% | ||
| Q3 25 | -43.4% | 14.8% | ||
| Q2 25 | -24.5% | 13.1% | ||
| Q1 25 | -2.7% | 9.6% | ||
| Q4 24 | -26.1% | 10.9% | ||
| Q3 24 | -26.5% | 11.2% | ||
| Q2 24 | -23.0% | 10.5% | ||
| Q1 24 | -23.7% | 6.1% |
净利率DHCDT
| Q4 25 | -5.6% | 7.8% | ||
| Q3 25 | -42.2% | 11.6% | ||
| Q2 25 | -23.9% | 10.0% | ||
| Q1 25 | -2.3% | 8.8% | ||
| Q4 24 | -23.0% | 82.9% | ||
| Q3 24 | -26.4% | 10.5% | ||
| Q2 24 | -26.3% | 9.7% | ||
| Q1 24 | -23.3% | 10.0% |
每股收益（稀释后）DHCDT
| Q4 25 | $-0.09 | $0.13 | ||
| Q3 25 | $-0.68 | $0.19 | ||
| Q2 25 | $-0.38 | $0.16 | ||
| Q1 25 | $-0.04 | $0.12 | ||
| Q4 24 | $-0.37 | $1.19 | ||
| Q3 24 | $-0.41 | $0.15 | ||
| Q2 24 | $-0.41 | $0.13 | ||
| Q1 24 | $-0.36 | $0.13 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $105.4M | $1.2B |
| 总债务越低越好 | $2.4B | — |
| 股东权益账面价值 | $1.7B | $2.7B |
| 总资产 | $4.4B | $4.1B |
| 负债/权益比越低杠杆越低 | 1.47× | — |
8季度趋势，按日历期对齐
现金及短期投资DHCDT
| Q4 25 | $105.4M | $1.2B | ||
| Q3 25 | $201.4M | $1.3B | ||
| Q2 25 | $141.8M | $1.3B | ||
| Q1 25 | $302.6M | $1.1B | ||
| Q4 24 | $144.6M | $1.0B | ||
| Q3 24 | $256.5M | $1.0B | ||
| Q2 24 | $265.6M | $1.0B | ||
| Q1 24 | $207.1M | $836.9M |
总债务DHCDT
| Q4 25 | $2.4B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $3.1B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益DHCDT
| Q4 25 | $1.7B | $2.7B | ||
| Q3 25 | $1.7B | $2.8B | ||
| Q2 25 | $1.9B | $2.7B | ||
| Q1 25 | $1.9B | $2.6B | ||
| Q4 24 | $2.0B | $2.6B | ||
| Q3 24 | $2.0B | $2.1B | ||
| Q2 24 | $2.1B | $2.1B | ||
| Q1 24 | $2.2B | $2.0B |
总资产DHCDT
| Q4 25 | $4.4B | $4.1B | ||
| Q3 25 | $4.7B | $4.1B | ||
| Q2 25 | $4.8B | $4.1B | ||
| Q1 25 | $5.0B | $4.1B | ||
| Q4 24 | $5.1B | $3.7B | ||
| Q3 24 | $5.3B | $3.3B | ||
| Q2 24 | $5.3B | $3.3B | ||
| Q1 24 | $5.3B | $3.4B |
负债/权益比DHCDT
| Q4 25 | 1.47× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.56× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-19.6M | $33.8M |
| 自由现金流经营现金流 - 资本支出 | $-166.4M | $27.2M |
| 自由现金流率自由现金流/营收 | -43.8% | 5.3% |
| 资本支出强度资本支出/营收 | 38.7% | 1.3% |
| 现金转化率经营现金流/净利润 | — | 0.84× |
| 过去12个月自由现金流最近4个季度 | $-280.3M | $465.5M |
8季度趋势，按日历期对齐
经营现金流DHCDT
| Q4 25 | $-19.6M | $33.8M | ||
| Q3 25 | $-49.3M | $32.0M | ||
| Q2 25 | $53.0M | $269.7M | ||
| Q1 25 | $-3.2M | $162.8M | ||
| Q4 24 | $112.2M | $42.2M | ||
| Q3 24 | $21.1M | $23.6M | ||
| Q2 24 | $44.3M | $230.7M | ||
| Q1 24 | $28.6M | $131.7M |
自由现金流DHCDT
| Q4 25 | $-166.4M | $27.2M | ||
| Q3 25 | $-89.8M | $27.8M | ||
| Q2 25 | $18.8M | $262.2M | ||
| Q1 25 | $-42.9M | $148.2M | ||
| Q4 24 | $-89.5M | $37.6M | ||
| Q3 24 | $-26.1M | $20.1M | ||
| Q2 24 | $3.3M | $227.4M | ||
| Q1 24 | $-18.1M | $121.9M |
自由现金流率DHCDT
| Q4 25 | -43.8% | 5.3% | ||
| Q3 25 | -23.1% | 5.6% | ||
| Q2 25 | 4.9% | 54.9% | ||
| Q1 25 | -11.1% | 33.3% | ||
| Q4 24 | -23.6% | 8.6% | ||
| Q3 24 | -7.0% | 4.8% | ||
| Q2 24 | 0.9% | 57.0% | ||
| Q1 24 | -4.9% | 32.0% |
资本支出强度DHCDT
| Q4 25 | 38.7% | 1.3% | ||
| Q3 25 | 10.4% | 0.8% | ||
| Q2 25 | 8.9% | 1.6% | ||
| Q1 25 | 10.2% | 3.3% | ||
| Q4 24 | 53.1% | 1.1% | ||
| Q3 24 | 12.6% | 0.8% | ||
| Q2 24 | 11.0% | 0.8% | ||
| Q1 24 | 12.6% | 2.6% |
现金转化率DHCDT
| Q4 25 | — | 0.84× | ||
| Q3 25 | — | 0.56× | ||
| Q2 25 | — | 5.62× | ||
| Q1 25 | — | 4.14× | ||
| Q4 24 | — | 0.12× | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | 5.97× | ||
| Q1 24 | — | 3.47× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DHC
| Senior Housing Operating Portfolio Segment | $323.4M | 85% |
| Rental Income | $56.2M | 15% |
DT
| Subscription And Circulation | $493.4M | 96% |
| Services | $22.1M | 4% |
